Succinimides

Ethosuximide, sold under the brand name Zarontin among others, is a medication used to treat absence seizures. It may be used by itself or with other antiseizure medications such as valproic acid. Ethosuximide is taken by mouth.

'''N-Bromosuccinimide or NBS''' is a chemical reagent used in radical substitution, electrophilic addition, and electrophilic substitution reactions in organic chemistry. NBS can be a convenient source of Br•, the bromine radical.

Succinimide is an organic compound with the formula (CH2)2(CO)2NH. This white solid is used in a variety of organic syntheses, as well as in some industrial silver plating processes. The compound is classified as a cyclic imide. It may be prepared by thermal decomposition of ammonium succinate.

'''N-Chlorosuccinimide (NCS''') is the organic compound with the formula C2H4(CO)2NCl. This white solid is used for chlorinations. It is also used as a mild oxidant. NCS is related to succinimide, but with N–Cl in place of N–H. The N–Cl bond is highly reactive, and NCS functions as a source of "Cl+".

Mesuximide (or methsuximide, methosuximide) is a succinimide anticonvulsant medication. It is sold as a racemate by Pfizer under the tradenames Petinutin (Switzerland) and Celontin (United States). The therapeutic efficacy of methosuximide is largely due to its pharmacologically active metabolite, N-desmethylmethosuximide, which has a longer half-life and attains much higher plasma levels than its parent.

'''N-Hydroxysuccinimide (NHS''') is an organic compound with the formula (CH2CO)2NOH. It is a white solid that is used as a reagent for preparing active esters in peptide synthesis. It can be synthesized by heating succinic anhydride with hydroxylamine or hydroxylamine hydrochloride.

Phensuximide is an anticonvulsant in the succinimide class.

chemical compound

Sunepitron (developmental code name CP-93,393) is a combined 5-HT1A receptor agonist and α2-adrenergic receptor antagonist. It was previously under development by Pfizer for the treatment of depression and anxiety. It made it to phase III clinical trials before being discontinued.

chemical compound

'''N-Iodosuccinimide (NIS''') is a reagent used in organic chemistry for the iodination of alkenes and as a mild oxidant.